sales@fusionmarketresearch.com + (210) 775-2636 (USA)

Medical Devices


Research Reports

Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

March 2020

Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of reusable insulin pen devices. China is expected to lead the reusable insulin pen market with a total market share of over 50% by 2022. Germany has shown its potential to become leading #2 market with more than XX% market share in 2016 and is expected to maintain its #2 position during the forecast period. United States is expected to become the third largest reusable insulin pen market by 2022. The research report titled “Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the reusable insulin pen market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into reusable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the reusable insulin pen market. The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market. All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints 1. Overall Diabetes Population (2011 – 2022) 2. Insulin Users (2011 – 2022) 3. Reusable (Cartridge) Insulin Pen Users (2011 – 2022) 4. Reusable (Cartridge) Insulin Pen Market (2011 – 2022) Ten Major Markets(10MM) Covered in the Report are as follows: 1. United States 2. United Kingdom 3. France 4. Italy 5. Spain 6. Germany 7. Japan 8. China 9. India 10. Brazil Key Companies Covered in the Report are as follows: 1. Novo Nordisk 2. Eli Lilly 3. Sanofi 4. Owen Mumford 5. Ypsomed 6. Biocon Ltd.


Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

March 2020

Diabetes Disposable Insulin Pen Market is likely to reach more than US$ 9 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022. Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices United States became the world’s biggest market of disposable insulin pen. United States market for disposable insulin pen is expected to reach more than US$ 2.5 Billion by the end of 2022. Japan will be the second–biggest market for disposable insulin pen which is expected to grow at a CAGR of X% by 2022. Germany is expected to be third biggest disposable insulin pen market being followed by Spain by the end of 2022. The research report titled “Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the disposable insulin pen market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into disposable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the disposable insulin pen market. The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly and Sanofi. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market. All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints: 1. Overall Diabetes Population (2011 – 2022) 2. Insulin Users (2011 – 2022) 3. Prefilled (Disposable) Insulin Pen Users (2011 – 2022) 4. Prefilled (Disposable) Insulin Pen Market (2011 – 2022) Ten Major Markets(10MM) Covered in the Report are as follows: 1. United States 2. United Kingdom 3. France 4. Italy 5. Spain 6. Germany 7. Japan 8. China 9. India 10. Brazil Key Companies Covered in the Report are as follows: 1. Novo Nordisk 2. Eli Lilly 3. Sanofi


United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022

March 2020

United States Insulin Pen Market is expected to reach more than US$2.5 Billion by 2022. Market growth can be attributed to factors such as diabetes patient population, user–friendly design, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs and technological advancements in the field of insulin pen devices. However, low patient awareness, lack of device education and training among physicians and perception of the higher cost is expected to hamper growth of the market during forecast period. “United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” provides a deep and thorough evaluation of the United States Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pen Market. The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market. Key Topics Covered in the Report • United States Diabetes Population (2011 – 2022) • United States Insulin Users (2011 – 2022) • United States Insulin Pen Users (2011 – 2022) • United States Reusable (Cartridge) Insulin Pen Users (2011 – 2022) • United States Prefilled (Disposable) Insulin Pen Users (2011 – 2022) • United States Insulin Pen Market (2011 – 2022) • United States Reusable (Cartridge) Insulin Pen Market (2011 – 2022) • United States Prefilled (Disposable) Insulin Pen Market (2011 – 2022) • United States Insulin Pen Market: Reimbursement & Regulation System • Key Companies Analysis • Key Drivers and Inhibitors of the United States Insulin Pen Market Key Companies Covered in the Report are as follows: • Novo Nordisk • Eli Lilly • Sanofi • Owen Mumford


United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022

March 2020

United States Insulin Pump Market is expected to reach US$ 3.8 Billion by the year end of 2022. Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period. This is the 2nd latest edition report published by the Market Report Publisher. “United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” provides a deep and thorough evaluation of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market. The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022. Key Topics Covered in the Report • United States Diabetes Population (2011 – 2022) • United States Insulin Pump Users and Market Analysis (2011 – 2022) • United States Insulin Pump Preferred Brand – By Product • United States Insulin Pump Market: Reimbursement & Regulation System • United States Insulin Pump Market – Major Deal Types • Insulin Pump Market Clinical Trail Insight by Phase, Company & Country • Key Companies Analysis • Key Drivers and Inhibitors of the United States Insulin Pump Market Key Companies Covered in the Report are as follows: • Insulet Corporation • Medtronic • Roche • Animas Corporation and • Tandem Diabetes Care "


North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022

March 2020

North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year end of 2022. Long–term Growth Projection: • Number of diabetes population in United States will increase to more than 33 Million by the year end of 2022 • In 2016, there were more than 5,00,000 insulin pump users in United States • Canada Insulin Pump market generated more than US$ 160 Million in 2016 • The US is the major market share holder for the North America Insulin Pump Market Increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle–compatible treatment options and technological advancement in insulin pump devices are the key factors driving the growth of the North America Insulin Pump Market. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period. “North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022” provides a deep and thorough evaluation of the North America Insulin Pump Market. The report provides an in–depth analysis of the type 1, type 2, newly diagnosed type 1 diabetes and overall diabetes population of all the three countries covered in the report. It provides an essential insights of insulin pump users in terms of volume in detail for latest trends, outlook and opportunities in all the three countries covered in the report. Market outlook in value terms has been analyzed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Key trends in terms of collaborations, partnerships and licensing agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the North America Insulin Pump Market. The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation, Tandem Diabetes Care, Microport and Sooil Development. The major market players are evaluated on various parameters such as company overview, product outlook, latest development and trends and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022. Key Topics Covered in the Report • United States, Canada & Mexico Diabetes Population Analysis (2011 – 2022) • North America Insulin Pump Users & Market Prospect & Growth (2011 – 2022) • North America Insulin Pump Users & Market Share – By Countries (2011 – 2022) • North America Insulin Pump Market Analysis – By Countries (2011– 2022) • United States Insulin Pump Users and Market Analysis (2011 – 2022) • United States Insulin Pump Preferred Brand – By Product • Canada Insulin Pump Users and Market Analysis (2011 – 2022) • Mexico Insulin Pump Users and Market Analysis (2011 – 2022) • North America (All 3 Countries) Insulin Pump Reimbursement & Regulation System • North America Insulin Pump Market – Major Deal Types • Insulin Pump Market Clinical Trail Insight by Phase, Company & Country • Key Drivers and Inhibitors of the North America Insulin Pump Market • Key Companies Analysis Major Countries Covered in This Report: • United States • Canada • Mexico Major Companies Covered in This Report: • Insulet Corporation • Medtronic • Roche • Animas Corporation and • Tandem Diabetes Care • Microport • Sooil Development


Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017-2022

March 2020

Diabetes Insulin Pen Market is anticipated to surpass US$ 5 Billion across the top 5 European countries of the France, Germany, Italy, Spain and United Kingdom by 2022. Long–term Growth Projection and Development: • Prefilled(Disposable) insulin pen grasps the dominant share in the top 5 European countries insulin pen market • In 2016, there were over 7,800 Thousand users of insulin pen in the top 5 European countries • Germany insulin pen market generated more than US$ 1.5 Billion in 2016 • Spain has shown its potential to become leading #2 market with around 20% market share in 2016 Market growth can be attributed to factors such as increasing number of patients with diabetes, high adoption rate, user–friendly design, surging popularity amid consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices. The research report titled “Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017-2022” examines the market, demand, competitive landscape and trends of the top 5 European markets of the insulin pen market. It provides an all-round analysis of overall number of patients with diabetes and insulin users. It offers information on users of insulin pens, specifically focusing on reusable and prefilled insulin pen users. Market outlook in value terms for the forecasted period for insulin pen market has been detailed in the report. The report also explores detailed description of growth drivers and barriers of the insulin pen market. The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford and Ypsomed. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market. Top 5 European Countries Covered in the Report Have Studied from 8 Viewpoints 1. Overall Diabetes Population (2011 – 2022) 2. Insulin Users (2011 – 2022) 3. Insulin Pen Users (2011 – 2022) 4. Reusable (Cartridge) Insulin Pen Users (2011 – 2022) 5. Prefilled (Disposable) Insulin Pen Users (2011 – 2022) 6. Insulin Pen Market (2011 – 2022) 7. Reusable (Cartridge) Insulin Pen Market (2011 – 2022) 8. Prefilled (Disposable) Insulin Pen Market (2011 – 2022) Top 5 European Countries Covered in the Report are as follows: 1. United Kingdom 2. France 3. Italy 4. Spain 5. Germany Key Companies Covered in the Report are as follows: 1. Novo Nordisk 2. Eli Lilly 3. Sanofi 4. Owen Mumford 5. Ypsomed


High Intensity Focused Ultrasound System Industry Insights, Trends, Outlook and Competitive Landscape To 2022

March 2020

High Intensity Focused Ultrasound System Industry Insights, Trends, Outlook and Competitive Landscape To 2022” report provides comprehensive understanding and unprecedented access to the High Intensity Focused Ultrasound System Industry entered by the world leading healthcare companies. The Research report presents a comprehensive assessment of the HIFU research sites, pre–clinical research sites, clinical research sites, technical research sites, commercial treatment sites and treatment by indication. Additionally, the report includes assessment of clinical trials and reimbursement pattern of the HIFU System. Key trends in terms of collaborations, distribution agreement and partnership deals are analysed with details. The report concludes with the profiles of major players in the HIFU System Industry. The key market players are evaluated on various parameters such as business overview, product portfolios, growth strategies, financial revenue and recent development & trends. Key Findings of the Report: • Profound Medical Corporation acquired Royal Philips Sonalleve MR-HIFU Business • Europe has the highest number of HIFU Research Sites • There are more than 100 HIFU Pre–Clinical Research Sites in the world • EDAP TMS will generate more than US$ XX Million HIFU revenue by 2022 • EDAP TMS partners with Vituro Health • SonaCare Medical granted FDA regulatory clearance for updated HIFU Prostate Tissue Ablation Device • Insightec HIFU revenue is likely to reach more than USD XX Million by 2022 • Siemens and Insightec sign agreement to expand access to exablate neuro technology • Theraclion HIFU revenue is likely to increase more than US$ XX Million by 2022 • Theraclion announces first patients treated in US pivotal multicentre FDA study • Eye Tech Care announced USD 25 Million funding and partnership agreement with Everpine Capital High Intensity Focused Ultrasound(HIFU) System Company Analysis - 23 Companies Covered 1) EDAP TMS 2) Sonacare Medical 3) Haifu Medical 4) Shanghai A&S Co., LTD 5) Insightec 6) Theraclion 7) Alpinion Medical Systems 8) FUS Instruments 9) Image Guided Therapy 10) Medsonic Ltd 11) Promedica Bioelectronics 12) Sumo Corporation Ltd 13) Mirabilis Medica 14) Eye Tech Care 15) Profound Medical Corp 16) Shenzhen Wikkon 17) Shenzhen PRO-HIFU Medical Tech. Co., Ltd 18) Verasonics 19) EpiSonica 20) Car Thera 21) Histosonics, Inc 22) Navifus 23) Toosonix


Diabetes Disposable Insulin Pen Market by Country (Germany, United Kingdom, France, Italy, Spain) Analysis, Growth Potential & Demand Forecast 2017 – 2022

March 2020

Diabetes Disposable Insulin Pen Market is anticipated to surpass US$ 4 Billion across the top 5 European countriesof the France, Germany, Italy, Spain and United Kingdom by 2022. “Diabetes Disposable Insulin Pen Market by Country (Germany, United Kingdom, France, Italy, Spain) Analysis, Growth Potential & Demand Forecast 2017 – 2022” report provides comprehensive understanding and unprecedented access to the Diabetes Disposable Insulin Pen Industry entered by the world leading healthcare companies. The research report examines the market, demand, competitive landscape and trends of the top 5 European markets of the diabetes disposable insulin pen market. It provides an all-round analysis of overall number of patients with diabetes and insulin users. It offers information on users of insulin pens, specifically focusing on prefilled(disposable) insulin pen users. Annual estimates and forecasts are provided for the period 2017 through 2024. Also, a five-year historic analysis is provided for these markets. The report also explores detailed description of growth drivers and barriers of the diabetes disposable insulin pen market. The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly and Sanofi. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the diabetes disposable insulin pen market. Top 5 European Countries Covered in the Report Have Studied from 4 Viewpoints: 1. Overall Diabetes Population (2011 – 2022) 2. Insulin Users (2011 – 2022) 3. Prefilled (Disposable) Insulin Pen Users (2011 – 2022) 4. Prefilled (Disposable) Insulin Pen Market (2011 – 2022) Top 5 European Countries Covered in the Report are as follows: 1. United Kingdom 2. France 3. Italy 4. Spain 5. Germany Key Companies Covered in the Report are as follows: 1. Novo Nordisk 2. Eli Lilly and Company 3. Sanofi


United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025

March 2020

United States Proton Therapy market is expected to reach nearly US$ 1 Billion, potentially US$ 7 Billion by 2025. Market growth can be attributed to factors such as rising cancer incidence, increasing number of proton therapy centers, decreasing cost of proton therapy treatment, technological advances and market adoption. However, high costs involved in the establishment of the center is likely to restrain growth in the forecast period. The research report titled “United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 - 2025” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States actual and potential proton therapy market. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies. The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US proton therapy centers from 2008 to 2015. The report also includes assessment of US reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the US proton therapy market. The report concludes with the profiles of major players in the US proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies and recent development & trends of the proton therapy market. Key Highlights of the United States Proton Therapy Market Report: • Proton Therapy Current Applications • Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy • Proton Therapy Competitive Analysis: By Company • Market Size & Analysis: United States Proton Therapy (2012 – 2025) • Market Opportunity Assessment: United States Proton Therapy (2012 – 2025) • United States Number of Treatment Rooms and Forecast (2012 – 2025) • United States Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company • United States Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator • United States Number of Patients Treated at Proton Therapy Centers (2008 – 2015) • United States Proton Therapy Reimbursement Scenario • Proton Therapy Center Component Analysis • Proton Therapy Clinical Trail Insight by Phase, Institute & Country • Proton Therapy Market – Major Deals • Key Market Drivers and Inhibitors of the United States Proton Therapy Market • Major Companies Analysis Key Companies Covered in the Report are as follows: • Optivus • Hitachi • Ion Beam Applications(IBA) • Varian Medical Systems • Mevion Medical Systems


United States Insulin Delivery Devices Market Outlook 2017: Key Product Categories (Insulin Pumps, Insulin Pens (Reusable, Disposable) Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

March 2020

United States Insulin Delivery Devices Market is anticipated to surpass US$ 6 Billion by 2022. Growth in US insulin delivery devices market can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, user–friendly design, help avoid over/under–dosing of insulin, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin delivery devices. The report titled “United States Insulin Delivery Devices Market Outlook 2017: Key Product Categories (Insulin Pumps, Insulin Pens (Reusable, Disposable) Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States insulin pump and insulin pen market. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2022. A comprehensive analysis has been done on market share of insulin delivery devices segment. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population in United States. It provides essential insights into total insulin delivery users, insulin pump users and insulin pen users with more focused–on reusable and prefilled insulin pen users. The report further sheds light on detailed US reimbursement scenario of insulin pump and insulin pen. Additionally, the report includes assessment of preferred insulin pump brand by the patients. The report also explores detailed description of growth drivers and inhibitors of the United States insulin delivery market. The report concludes with the profiles of major players in the insulin delivery devices market such as Insulet Corporation, Medtronic, Roche, Tandem Diabetes Care, Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford. The major market players are evaluated on various parameters such as company overview, product portfolios and latest development and trends of the insulin delivery devices market. Key Highlights of the United States Insulin Delivery Devices Market Report: • Diabetes Population (2011 – 2022) • Overall Insulin Delivery Users Snapshot (2011 – 2022) • Insulin Pump Users (2011 – 2022) • Type 1 Diabetes Insulin Pump Users (2011 – 2022) • Type 2 Diabetes Insulin Pump Users (2011 – 2022) • Insulin Pen Users (2011 – 2022) • Reusable (Cartridge) Insulin Pen Users (2011 – 2022) • Prefilled (Disposable) Insulin Pen Users (2011 – 2022) • Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share (2011 – 2022) • Overall Insulin Delivery Devices: Market Snapshot (2011 – 2022) • Insulin Pump Market Size (2011 – 2022) • Insulin Pen Market Size (2011 – 2022) • Reusable (Cartridge) Insulin Pen Market (2011 – 2022) • Prefilled (Disposable) Insulin Pen Market (2011 – 2022) • Insulin Delivery Devices Segment (Insulin Pump & Insulin Pen) Market Share (2011 – 2022) • Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share (2011 – 2022) • Insulin Pump Preferred Brand – By Product (2011 – 2022) • Insulin Pump and Pen Reimbursement Scenario (2011 – 2022) • Key Drivers and Inhibitors of the Insulin Delivery Devices Market • Key Companies Analysis The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are: • Insulet Corporation • Medtronic • Roche • Tandem Diabetes Care • Novo Nordisk • Eli Lilly • Sanofi • Owen Mumford Key Deliverables in the Study • Market Definition for the specified topic along with identification of key drivers and inhibitors for the market • Trending factors influencing the market shares of the United States Insulin Delivery Devices • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments • It provides a five-year forecast which helps to provide a long-term assessment of developments in the United States Insulin Delivery Devices Market. • Identification and Analysis of the Macro and Micro factors that affect the United States Insulin Delivery Devices Market • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities • A comprehensive list of key market players along with the analysis of their current product portfolios and recent development


Page : 24



Contact Us

Address

Pride Icon, Office No - 709,Thite Nagar, Kharadi,Pune, Maharashtra, India 411014

Phone Number

+(210) 775-2636